US Stock MarketDetailed Quotes

PALI Palisade Bio

Watchlist
  • 1.0400
  • +0.0100+0.97%
Close Feb 14 16:00 ET
  • 1.0322
  • -0.0078-0.75%
Post 17:43 ET
2.88MMarket Cap-0.08P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Palisade Bio (PALI.US)$ Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
    2 MINUTES AGO, 8:45 AM EST
    VIA GLOBENEWSWIRE
    Data presented at the 2025 Crohn's and Colitis Congress 
    PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure
    Company advancing Phase 1a/b study of PALI-2108 and has demonstrated a favorable safety profile in single-ascending-dose cohorts
    $Palisade Bio (PALI.US)$
    Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
    Monday, 10th February at 8:45 am
    Data presented at the 2025 Crohn's and Colitis Congress 
    PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure
    Company advancing Phase 1a/b study of PALI-2108 and has demonstrated a favorable safety profile in single-ascending-dose cohorts
    Carlsbad, CA, Fe...
    $Palisade Bio (PALI.US)$
    Palisade Bio Selected for Poster Presentation at the 2025 Crohn's & Colitis Congress
    Wednesday, 29th January at 8:45 am
    Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ: PALI) ("Palisade", "Palisade Bio", or the "Company"), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that its abstract has been accepte...
Read more

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.